Agarwal, Sri Mahavir
Centre for Addiction and Mental Health · University of Toronto
8 papers on CoChatORCID 0000-0002-2705-5146
Most cited papers
- Verified
Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health
Stogios, N., Gdanski, A., Gerretsen, P., Chintoh, A. F., Graff-Guerrero, A., Rajji, T. K., Remington, G., Hahn, M. K., & Agarwal, S. M. (2021) · npj Schizophrenia
Schizophrenia research and treatmentHeart Rate Variability and Autonomic Control
Cited by 98
- Verified
Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series
Prasad, F., De, R., Korann, V., Chintoh, A. F., Remington, G., Ebdrup, B. H., Siskind, D., Knop, F. K., Vilsbøll, T., Fink-Jensen, A., et al. (2023) · Therapeutic Advances in Psychopharmacology
Pharmacology and Obesity TreatmentSchizophrenia research and treatment
Cited by 88
- Verified
Metformin for the prevention of antipsychotic-induced weight gain: guideline development and consensus validation
Carolan, A., Hynes-Ryan, C., Agarwal, S. M., Bourke, R., Cullen, W., Gaughran, F., Hahn, M. K., Krivoy, A., Lally, J., Leucht, S., et al. (2025) · Schizophrenia Bulletin
Schizophrenia research and treatmentPharmacology and Obesity Treatment
Cited by 70
- Verified
Clinical correlates of parametric digit-symbol substitution test in schizophrenia
Amaresha, A. C., Danivas, V., Shivakumar, V., Agarwal, S. M., Kalmady, S. V., Narayanaswamy, J. C., & Venkatasubramanian, G. (2014) · Asian Journal of Psychiatry
Schizophrenia research and treatmentPsychological Testing and Assessment
Cited by 43
- Verified
Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial
Agarwal, S. M., Panda, R., Costa-Dookhan, K. A., MacKenzie, N. E., Treen, Q. C., Caravaggio, F., Hashim, E., Leung, G., Kirpalani, A., Matheson, K., et al. (2021) · Translational Psychiatry
Schizophrenia research and treatmentDiabetes Treatment and Management
Cited by 41
- Verified
The impact of weight gain on antipsychotic nonadherence or discontinuation: a systematic review and meta-analysis
De, R., Smith, E. C. C., Navagnanavel, J., Au, E., Maksyutynska, K., Papoulias, M., Singh, R., Panganiban, K. J., Humber, B., Mohr, G. H., et al. (2025) · Acta Psychiatrica Scandinavica
Schizophrenia research and treatmentMedication Adherence and Compliance
Cited by 39
- Verified
Cerebellar volume deficits in medication-naive obsessive compulsive disorder
Narayanaswamy, J. C., Jose, D., Kalmady, S. V., Agarwal, S. M., Venkatasubramanian, G., & Janardhan Reddy, Y. C. (2016) · Psychiatry Research: Neuroimaging
Obsessive-Compulsive Spectrum DisordersDeep Brain Stimulation and Movement Disorders
Cited by 25
- Verified
The Effect of Semaglutide on Antipsychotic-Induced Weight Gain and Other Metabolic Parameters, among a Cohort of Inpatients
De, R., Amin Alfatwa, Y., Kanagasundaram, P., Saragosa, J. E., Chan, J., Remington, G., Retnakaran, R., Sanches, M., Sockalingam, S., Agarwal, S. M., et al. (2026) · Schizophrenia Bulletin
Schizophrenia research and treatmentDiabetes Treatment and Management
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free